Experts in next-generation 3D cell culture gathered at the inaugural New Frontiers in 3D Cell Culture-based Screening Technologies Conference, held Thursday, October 13 at Johns Hopkins University in Baltimore, MD. Conceived and organized by InSphero AG, the National Center for Advancing Translational Sciences (NCATS), the Centers for Alternatives to Animal Testing (CAAT), and Promega Corporation, the first annual conference brought together thought leaders from major disciplines to discuss application of 3D tissue models to improve in vitro assays used for drug discovery and toxicity testing.
Michael Gottesman, MD, Chief of the Laboratory of Cell Biology at the National Cancer Institute and Deputy Director for Intramural Research, National Institutes of Health, and Thomas Hartung, MD, PhD of the Johns Hopkins Bloomberg School of Public Health and Director of CAAT, delivered keynote presentations at the one-day event. Themed sessions featured presentations from some of the world’s leading pharmaceutical, regulatory, and academic research ...
